Hyperthermic intraperitoneal chemotherapy (HIPEC) is a technique that delivers high doses of heated chemotherapy directly to abdominal organs to kill cancer cells that may remain after surgical removal of visible tumors. It is typically used in combination with cytoreductive surgery to treat advanced-stage abdominal cancers such as peritoneal mesothelioma, stomach cancer, appendix cancer, and colorectal cancer, as well as ovarian cancer. Smilow Cancer Hospital physicians are national leaders in the delivery of HIPEC therapy, with a deep understanding of the types of cancer it can be used to treat, the nuances of the therapy, and its effectiveness. Clinical trials using HIPEC therapy are also available.
HIPEC at Smilow Cancer Hospital includes a skilled team of surgeons, oncologists, palliative care physicians, gastroenterologists, radiologists, pathologists, dietitians, oncology nurses, and scientists. Because HIPEC provides a localized, targeted concentration of chemotherapy, systemic side effects are minimized and the outlook can be promising for patients with advanced cancers.
For Appointments and Referrals: 203-785-3577